propionylcarnitine has been researched along with Cardiomyopathy, Dilated in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (66.67) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Faa, G; Littarru, GP; Mancinelli, R; Vargiu, R | 1 |
Arrigoni-Martelli, E; Corsico, N; Mancinelli, R; Manni, E; Maresca, P | 2 |
3 other study(ies) available for propionylcarnitine and Cardiomyopathy, Dilated
Article | Year |
---|---|
Positive inotropic effect of coenzyme Q10, omega-3 fatty acids and propionyl-L-carnitine on papillary muscle force-frequency responses of BIO TO-2 cardiomyopathic Syrian hamsters.
Topics: Animals; Cardiomyopathies; Cardiomyopathy, Dilated; Carnitine; Cricetinae; Fatty Acids, Omega-3; Male; Mesocricetus; Models, Animal; Myocardial Contraction; Papillary Muscles; Stimulation, Chemical; Ubiquinone | 2008 |
Propionyl-L-carnitine improves mechanical performance of papillary muscle from dilated cardiomyopathic hamsters.
Topics: Animals; Cardiomyopathy, Dilated; Cardiotonic Agents; Carnitine; Cricetinae; Myocardial Contraction; Papillary Muscles | 1995 |
Positive action of propionyl-L-carnitine on mechanical performance of papillary muscle from Syrian hamsters with hereditary dilated cardiomyopathy.
Topics: Administration, Oral; Analysis of Variance; Animals; Biomechanical Phenomena; Cardiomyopathy, Dilated; Cardiotonic Agents; Carnitine; Cricetinae; Disease Models, Animal; Genetic Diseases, Inborn; Male; Mesocricetus; Myocardial Contraction; Papillary Muscles | 1995 |